| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |